Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas

Journal of Neurosurgery

Volumn 104 PEDIATRICS, Issue SUPPL. 5, 2006, Pages 314-320

  Bartels, Ute ^a   Hawkins, Cynthia ^b   Ma, Jing ^b   Ho, Michael ^b   Dirks, Peter ^b   Rutka, James ^b   Stephens, Derek ^b   Bouffet, Eric ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

Angiogenic feature; Microvessel density; Optic pathway glioma; Pediatric neurosurgery; Prognostic marker

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTINEOPLASTIC AGENT; KI 67 ANTIGEN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; TUMOR MARKER;

ADOLESCENT; ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHALAMUS TUMOR; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MICROVASCULATURE; NEUROFIBROMATOSIS; OPTIC NERVE GLIOMA; PEDIATRIC SURGERY; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH; TUMOR VASCULARIZATION; VISUAL SYSTEM; CELL DIVISION; DISEASE COURSE; ENZYME IMMUNOASSAY; MICROCIRCULATION; MINIMAL RESIDUAL DISEASE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; VASCULARIZATION;

ADOLESCENT; CELL DIVISION; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; HUMANS; HYPOTHALAMIC NEOPLASMS; IMMUNOENZYME TECHNIQUES; INFANT; MICROCIRCULATION; NEOPLASM, RESIDUAL; NEOVASCULARIZATION, PATHOLOGIC; OPTIC NERVE GLIOMA; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 33747594734     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/ped.2006.104.5.314     Document Type: Article

References (43)

1. Alshail E, Rutka JT, Becker LE, Hoffman HJ: Optic chiasmatic-hypothalamic glioma. Brain Pathol 7:799-806, 1997
2. Astrup J: Natural history and clinical management of optic pathway glioma. Br J Neurosurg 17:327-335, 2003
3. Bouffet E: Common brain tumours in children: diagnosis and treatment. Paediatr Drugs 2:57-66, 2000
4. Bowers DC, Gargan L, Kapur P, Reisch JS, Mulne AF, Shapiro KN, et al: Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. J Clin Oncol 21:2968-2973, 2003
5. Dirks PB, Jay V, Becker LE, Drake JM, Humphreys RP, Hoffman HJ, et al: Development of anaplastic changes in low-grade astrocytomas of childhood. Neurosurgery 34:68-78, 1994
6. Dirven CMF, Koudstaal J, Mooij JJA, Molenaar WM: The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up. J Neurooncol 37:9-16, 1998
7. Fisher BJ, Naumova E, Leighton CC, Naumov GN, Kerklviet N, Fortin D, et al: Ki-67: a prognostic factor for low-grade glioma? Int J Radiat Oncol Biol Phys 52:996-1001, 2002
8. Folkerth RD: Descriptive analysis and quantification of angiogenesis in human brain tumors. J Neurooncol 50:165-172, 2000
9. Gajjar A, Sanford RA, Heideman R, Jenkins JJ, Walter A, Li Y, et al: Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol 15:2792-2799, 1997
10. Gesundheit B, Klement G, Senger C, Kerbel R, Kieran M, Baruchel S, et al: Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood. Med Pediatr Oncol 41:516-526, 2003
11. Giannini C, Scheithauer BW, Burger PC, Christensen MR, Wollan PC, Sebo TJ, et al: Cellular proliferation in pilocytic and diffuse astrocytomas. J Neuropathol Exp Neurol 58:46-53, 1999
12. Gnekow AK, Kortmann RD, Pietsch T, Emser A: Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy. Report from the multicenter treatment study for children and adolescents with a low grade glioma - HIT-LGG 1996 - of the Society of Pediatric Oncology and Hematology (GPOH). Klin Pädiatr 216:331-342, 2004
13. Goldbrunner RH, Wagner S, Roosen K, Tonn JC: Models for assessment of angiogenesis in gliomas. J Neurooncol 50:53-62, 2000
14. Grill J, Laithier V, Rodriguez D, Raquin MA, Pierre-Kahn A, Kalifa C: When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr 159:692-696, 2000
15. Grotzer MA, Wiewrodt R, Janss AJ, Zhao H, Cnaan A, Sutton LN, et al: High microvessel density in primitive neuroectodermal brain tumors of childhood. Neuropediatrics 32:75-79, 2001
16. Grunstein J, Masbad JJ, Hickey R, Giordano F, Johnson RS: Isoforms of vascular endothelial growth factor act in a coordinate fashion To recruit and expand tumor vasculature. Mol Cell Biol 20:7282-7291, 2000
17. Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, et al: Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 75:1051-1059, 1995
18. Jenkin D, Angyalfi S, Becker L, Berry M, Buncic R, Chan H, et al: Optic glioma in children: surveillance, resection, or irradiation? Int J Radiat Oncol Biol Phys 25:215-225, 1993
19. Kleihues P, Cavenee WK: Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000
20. Komotar RJ, Burger PC, Carson BS, Brem H, Olivi A, Goldthwaite PT, et al: Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas. Neurosurgery 54:72-80, 2004
21. Komotar RJ, Mocco J, Jones JE, Zacharia BE, Tihan T, Feldstein NA, et al: Pilomyxoid astrocytoma: diagnosis, prognosis, and management. Neurosurg Focus 18 (6a):E7, 2005
22. Kornreich L, Blaser S, Schwarz M, Shuper A, Vishne TH, Cohen IJ, et al: Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. AJNR Am J Neuroradiol 22:1963-1969, 2001
23. Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F, et al: Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy - results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol 21:4572-4578, 2003
24. Leon SP, Folkerth RD, Black PM: Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77:362-372, 1996
25. Machein MR, Plate KH: VEGF in brain tumors. J Neurooncol 50:109-120, 2000
26. Machen SK, Prayson RA: Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases. Hum Pathol 29:1511-1516, 1998
27. Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, et al: High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20:4209-4216, 2002
28. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22, 1999
29. Oxenhandler DC, Sayers MP: The dilemma of childhood optic gliomas. J Neurosurg 48:34-41, 1978
30. Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, et al: Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747-754, 1997
31. Packer RJ, Sutton LN, Bilaniuk LT, Radcliffe J, Rosenstock JG, Siegel KR, et al: Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol 23:79-85, 1988
32. Parsa CF, Hoyt CS, Lesser RL, Weinstein JM, Strother CM, Muci-Mendoza R, et al: Spontaneous regression of optic gliomas. Thirteen cases documented by serial neuroimaging. Arch Ophthalmol 119:516-529, 2001
33. Perilongo G, Moras P, Carollo C, Battistella A, Clementi M, Laverda A, et al: Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: a real possibility. J Child Neurol 14:352-356, 1999
34. Puduvalli VK, Sawaya R: Antiangiogenesis - therapeutic strategies and clinical implications for brain tumors. J Neurooncol 50:189-200, 2000
35. Schröder S, Baumann-Schroder U, Hazim W, Haase W, Mautner VF: Langzeitverlauf von Gliomen der Sehbahn bei Neurofibromatose Typ 1. Klin Monatsbl Augenheilkd 215:349-354, 1999
36. Shapiro WR: Current therapy for brain tumors. Back to the future. Arch Neurol 56:429-432, 1999
37. Shuper A, Horev G, Kornreich L, Michowiz S, Weitz R, Zaizov R, et al: Visual pathway glioma: an erratic tumor with therapeutic dilemmas. Arch Dis Child 76:259-263, 1997
38. Silva MM, Goldman S, Keating G, Marymont MA, Kalapurakal J, Tomita T: Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy. Pediatr Neurosurg 33:151-158, 2000
39. Tihan T, Fisher PG, Kepner JL, Godfraind C, McComb RD, Goldthwaite PT, et al: Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol 58:1061-1068, 1999
40. Tow SL, Chandela S, Miller NR, Avellino AM: Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 28:262-270, 2003
41. Walker D: Recent advances in optic nerve glioma with a focus on the young patient. Curr Opin Neurol 16:657-664, 2003
42. Weidner N: Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36:169-180, 1995
43. Zagzag D, Amirnovin R, Greco MA, Yee H, Holash J, Wiegand SJ, et al: Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest 80:837-849, 2000